1-11 of 11
P. Anderlini
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Prophylaxis of Graft-Versus-Host Disease (GVHD) with Pentostatin, Tacrolimus, and “Mini”-Methotrexate (MTX): A Phase I/II Controlled, Randomized Study in Unrelated Donor (UD) Transplantation.

Marcos de Lima, B. Andersson, M. Fernadez-Vina, S. Giralt, D. Couriel, E. Shpall, U. Popat, M. Qazilbash, A. Alousi, P. Cano, D. Bosque, C. Hosing, S. Qureshi, L. de Padua, M. Munsell, P. Anderlini, R. Jones, M. Westmoreland, A. Gulbis, R. Champlin
Journal: Blood
Blood (2007) 110 (11): 40.
https://doi.org/10.1182/blood.V110.11.40.40
Published: 2007
Journal Articles

Higher Rate of Thrombotic Thrombocytopenic Pupura (TTP) Associated with Graft Versus Host Disease (GVHD) and Unrelated Donor Bone Marrow Transplantation (BMT).

B. Oran, MD, A. Aleman, MD, E. J. Shpall, MD, C. Hosing, MD, M. Korbling, MD, P. Anderlini, MD, R. Champlin, MD, M. Donato, MD
Journal: Blood
Blood (2005) 106 (11): 1111.
https://doi.org/10.1182/blood.V106.11.1111.1111
Published: 2005
Journal Articles

Unrelated-Donor PBSC Collection Facilitated by the NMPD, 1999–2005: Efficacy and Toxicities, Serious Unexpected Events, and Outcomes of Standard vs. Large Volume Collections.

Michael Pulsipher, S. Kurian, S. F. Leitman, P. Anderlini, M. Haagenson, B. Logan, M. M. Horowitz, D. L. Confer
Journal: Blood
Blood (2005) 106 (11): 1965.
https://doi.org/10.1182/blood.V106.11.1965.1965
Published: 2005
Journal Articles

Long-Term Follow-Up of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) with Fludarabine and Melphalan (FM) Reduced Intensity Conditioning (RIC) for High-Risk AML/MDS.

B. Oran, R. Saliba, S. Giralt, D. Couriel, A. Carrasco-Yalan, C. Hosing, M. Shahjahan, E. de Meis, A. Anagnostopoulos, P. Anderlini, S. Ghosh, I. Khouri, R. Champlin, M. de Lima
Journal: Blood
Blood (2005) 106 (11): 838.
https://doi.org/10.1182/blood.V106.11.838.838
Published: 2005
Journal Articles

Results of a Phase I/II Study of Gemtuzumab Ozogamicin Added to Fludarabine (F), Melphalan (M) and Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Relapsed Myeloid Leukemias.

Marcos de Lima, S. Giralt, Z. Caldera, G. McCormick, M. Qazilbash, P. Anderlini, E. J. Shpall, C. Hosing, M. Donato, S. Kornblau, I. Khouri, T. Martin, D. Couriel, R. Champlin
Journal: Blood
Blood (2005) 106 (11): 841.
https://doi.org/10.1182/blood.V106.11.841.841
Published: 2005
Journal Articles

Pentostatin, Tacrolimus, and “Mini”-Methotrexate for Graft-Versus-Host Disease (GVHD) Prophylaxis: A Phase I/II Controlled, Randomized Study.

M. de Lima, D. Couriel, M. Munsell, M. Westmoreland, H. Shah, J. deJesus, C. Hosing, S. Ghosh, P. Anderlini, J. Gajewski, B. Andersson, S. Kornblau, B. Hocking, C. Ippoliti, S. Giralt, E. Shpall, R. Champlin
Journal: Blood
Blood (2004) 104 (11): 727.
https://doi.org/10.1182/blood.V104.11.727.727
Published: 2004
Journal Articles

Phase I/II Study of Gemtuzumab Ozogamicin (GO), Fludarabine and Melphalan (FM) Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in AML/MDS.

M. de Lima, P. Thall, M. Shahjahan, W. Xuemei, D. Couriel, P. Anderlini, C. Hosing, M. Qazilbash, G. McCormick, C. Ippoliti, M. Donato, T. Martin, L. Metoyer, L. Griffin, P. Kebriaei, R. Champlin, S. Giralt
Journal: Blood
Blood (2004) 104 (11): 1824.
https://doi.org/10.1182/blood.V104.11.1824.1824
Published: 2004
Journal Articles

Peripheral blood stem cell apheresis in normal donors: the neglected side [letter; comment]

P Anderlini, D Przepiorka, R Champlin, M Korbling
Journal: Blood
Blood (1996) 88 (9): 3663–3664.
https://doi.org/10.1182/blood.V88.9.3663.bloodjournal8893663
Published: 1996
Journal Articles

Biologic and clinical effects of granulocyte colony-stimulating factor in normal individuals

P Anderlini, D Przepiorka, R Champlin, M Korbling
Journal: Blood
Blood (1996) 88 (8): 2819–2825.
https://doi.org/10.1182/blood.V88.8.2819.bloodjournal8882819
Published: 1996
Journal Articles

Treatment of chronic myelogenous leukemia: current status and investigational options [see comments]

HM Kantarjian, S O'Brien, P Anderlini, M Talpaz
Journal: Blood
Blood (1996) 87 (8): 3069–3081.
https://doi.org/10.1182/blood.V87.8.3069.bloodjournal8783069
Published: 1996
Journal Articles

Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy- 1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease

M Korbling, YO Huh, A Durett, N Mirza, P Miller, H Engel, P Anderlini, K van Besien, M Andreeff, D Przepiorka
Journal: Blood
Blood (1995) 86 (7): 2842–2848.
https://doi.org/10.1182/blood.V86.7.2842.2842
Published: 1995